XML 46 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2022
Revenue from Contract with Customer [Abstract]  
Disaggregation of revenue
The following table represents Evolent’s revenue disaggregated by segment and end-market for (in thousands):
For the Three Months Ended March 31,
2022202120222021
Evolent Health ServicesClinical Solutions
Medicaid$66,914 $60,929 $63,587 $43,339 
Medicare4,833 8,338 99,566 85,783 
Commercial and other35,111 15,571 27,046 1,111 
Total$106,858 $84,838 $190,199 $130,233 
Contract with customer, asset and liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of March 31, 2022 and December 31, 2021 (in thousands):
March 31, 2022December 31, 2021
Short-term receivables (1)
$176,300 $129,012 
Long-term receivables (1)
4,958 4,877 
Short-term deferred revenue13,288 11,944 
Long-term deferred revenue4,019 4,437 
————————
(1)Excludes pharmacy claims receivable and premiums receivable.

Changes in deferred revenue for the three months ended March 31, 2022 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$16,381 
Reclassification to revenue, as a result of performance obligations satisfied(10,124)
Cash received in advance of satisfaction of performance obligations11,050 
Balance as of end of period$17,307